EUVIMEDEUVIMED entdecken
Editorial

Tumour extravasation of nanomedicine: The EPR and alternative pathways

Youqing Shen, You Han Bae

Advanced Drug Delivery Reviews · 2023

DOI: 10.1016/j.addr.2023.114707 ↗

Kurz gefasst

Editorial in der Zeitschrift Advanced Drug Delivery Reviews, 2023. Verfasst von Youqing Shen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, Key Laboratory of Biomass Chemical Engineering of Ministry of Educat…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansNanomedicineDrug Delivery SystemsPermeability

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Zhejiang Key Laboratory of Smart Biomaterials and Center for Bionanoengineering, Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang Universi…
  • Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, USA.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shen, Y., & Bae, Y. H. (2023). Tumour extravasation of nanomedicine: The EPR and alternative pathways. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2023.114707

Vancouver

Shen Y, Bae YH. Tumour extravasation of nanomedicine: The EPR and alternative pathways. Advanced Drug Delivery Reviews. 2023. doi:10.1016/j.addr.2023.114707

BibTeX
@article{Shen2023,
  author = {Shen, Youqing and Bae, You Han},
  title = {Tumour extravasation of nanomedicine: The EPR and alternative pathways},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  doi = {10.1016/j.addr.2023.114707}
}
Kostenlos starten →